Injectable Drug Delivery Articles

1. Delivery Strategy For Next-Gen Cardiac Gene Therapies 3/12/2026

   As the field matures, the most transformative gene therapies in heart health are treating delivery not as an afterthought but as a fundamental principle.

2. Injecting Cancer Killers: Intratumoral Therapy For Solid Tumors 3/5/2026

   Intratumoral injection bypasses the tumor’s physical defenses entirely, killing cancer cells and creating a personalized immune response that destroys solid tumors.

3. GenAI: The Muscle Behind Strong Regulatory Intelligence For Combination Products 3/2/2026

   In this article, combination product consultant Doug Mead provides the rationale and offers guidance for using GenAI tools to search regulatory databases. He shows the benefits for biopharma developers of conducting “precedent research” into previous regulatory pathways and results for similar or related drug delivery product submissions. 

4. Regulatory Precedents For Drug Delivery: Uncovering Clues To Successful Submissions 3/2/2026

   In this article, Chief Editor Tom von Gunden considers the need for and benefit of conducting AI-based research into regulatory precedents for drug delivery submissions and approvals. He consults combination products consultant Doug Mead on best practices in bolstering regulatory intelligence and regulatory approval success by way of advanced search methods. 

5. RNA Delivery Technologies: Industrial Applications And Emerging Innovations 2/10/2026

   RNA delivery is moving from breakthrough to backbone. This review examines how LNPs and emerging carriers are reshaping scalability, targeting, manufacturing, and real-world deployment of RNA therapeutics.

6. 4 Opportunities For Advancing Drug Delivery 2/3/2026

   In this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies. 

7. In Vivo's Biggest Threat — Comparison To Old Models 1/23/2026

   In vivo CAR-T is not simply ex vivo without a manufacturing step. It is a different modality that relies on biological systems to regulate outcomes.

8. Conducting A Medical Device Stability Study: A Practical Guide 1/7/2026

   Stability studies measure how medical devices respond to environmental stresses such as temperature, humidity, light, and time. Let's take a closer look at designing and conducting a stability study.

9. Nanotechnology Drug Delivery: A Market Overview 1/6/2026

   New market research reveals the scientific, geopolitical, and business trends driving growth in the nanotechnology drug delivery market.

10. Combination: The Drug Delivery Word Of The Year For 2026 12/30/2025

    In this article, Chief Editor Tom von Gunden explains why he sees 2026 as the year combination products and therapies become fully central to drug and biologics product development, delivery, and regulatory. He points to personalized medicine and patient self-administration as key factors shaping his view of the drug delivery landscape.